Effect of Fat Intake on the Inflammatory Process and Cardiometabolic Risk in Obesity After Interdisciplinary Therapy
G Jamar1, L P Pisani1, A Medeiros1
1Post Graduate Program of Interdisciplinary Health Sciences, Federal University of São Paulo - UNIFESP - Santos, São Paulo, Brazil.
Summary
Reducing dietary fat and carbohydrates aids weight loss in obese women. Lowering fat intake significantly impacted inflammation and cardiovascular risk, while lower carbohydrate intake affected body composition and leptin levels.
Area of Science:
- Nutrition Science
- Obesity Research
- Metabolic Health
Background:
- Obesity and its comorbidities are linked to diet, sedentary lifestyles, and excessive sugar/fat intake.
- Understanding macronutrient roles in weight loss is crucial for effective obesity treatment.
Purpose of the Study:
- To investigate how macronutrient type influences health benefits during weight loss in obese women.
- To assess the impact of dietary changes on body composition, metabolic parameters, and inflammatory markers.
Main Methods:
- A 26-week interdisciplinary therapy program for 30 obese women, including nutritional counseling, exercise, and psychological support.
- Assessment of anthropometrics, body composition (bioelectrical impedance analysis), food intake, and blood biomarkers (metabolic and adipokines).
Main Results:
- Significant reductions in anthropometric and body composition variables were observed.
- Improvements in LDL-cholesterol, PAI-1, leptin, CRP, ICAM-1, and VCAM-1.
- Lower carbohydrate and fat intake correlated with weight loss; reduced fat intake had a greater impact on inflammation.
Conclusions:
- Macronutrient type significantly influences the health benefits derived from weight loss in obese individuals.
- Dietary fat reduction is key for mitigating inflammation and cardiovascular risk.
- Carbohydrate reduction impacts body composition and leptin levels, contributing to weight management.
Related Concept Videos
Atherosclerosis III: Management
589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
384
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
384
Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
284
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
284
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Inflammation
64.4K
Overview
64.4K


